title: CD20-negative relapse after (131)I-anti-CD20 therapy.
authors.forename: P
authors.initials: P
authors.lastname: Venugopal
authors.forename: W T
authors.initials: WT
authors.lastname: Leslie
authors.forename: T
authors.initials: T
authors.lastname: O'Brien
authors.forename: S A
authors.initials: SA
authors.lastname: Gregory
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000473:pathology; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab